68669-522 : Betimol 2.5 mg/ml Ophthalmic Solution


NDC: 68669-522
Labeler: Vistakon Pharmaceuticals LLC
Product Type: Human Prescription Drug
Drug Name:  Betimol
Dosage Form: Ophthalmic Solution
Application #: NDA020439
Rev. Date: 


NDC Package Codes:

  • 68669-522-05: 5 ML IN 1 BOTTLE (68669‑522‑05)

Active Ingredients:

  • Timolol

Dosage Strength:

  • 2.5 mg/mL

Related Products:

Based on records with the same trade name.
  • 68669-525 Betimol 5 mg/ml Ophthalmic Solution by Vistakon Pharmaceuticals LLC
  • 76478-001 Betimol 2.56 mg/ml Ophthalmic Solution/ Drops by Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) (968937719)
  • 76478-002 Betimol 5.12 mg/ml Ophthalmic Solution/ Drops by Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) (968937719)
  • 82584-001 Betimol 2.56 mg/ml Ophthalmic Solution/ Drops by Thea Pharma Inc.
  • 82584-002 Betimol 5.12 mg/ml Ophthalmic Solution/ Drops by Thea Pharma Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68669-522 QR Code

< Prev: 68669-145Next: 68669-525 >

Related Discussions:

Dorzolamide-timolol opth
Has anyone taken the generic verision of Dorzolamide-Timolol and is it as good as the non-generic verision? Thanks. s. h... 1 reply
Dorzolamide - Timolol Opth Soln 10 ML
I have been on Dorzolamide - Timolol for the past eight months , for use in one eye . This drug has reduced my eye press... 1 reply
Istalol timolol maleate ophthalmic solution
glaucoma...
Is there any new eye drops for glaucoma iop control I am already using latanoprost xalatan and timolol maleate and Alphagan
I am using all the three drops but i feel my iop is still not under control. Would there be any new drug out in market ?...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.